A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

A new study published in the Annals of Surgical Oncology revealed that individuals with little muscle mass, segmentectomy ...

Jan. 9, 2025 — Researchers have shown that a test called ORACLE can predict lung cancer survival at the point ... with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

Teos and GSK were the last to report a new setback in TIGIT targeting for non-small cell lung cancer patients. Read why I am ...

Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy ...

Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...

For patients with EGFR-mutated NSCLC, treatment options in the frontline include osimertinib monotherapy, amivantamab with ...

BeiGene has announced that its Tevimbra (tislelizumab) has been approved by the European Commission (EC) as part of a ...

Almost a third of Americans are more than a year behind in cancer screening, more than half of them because of out-of-pocket ...